Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Radiat Res. 2023 Mar 1;199(3):217–228. doi: 10.1667/RADE-22-00048.1

TABLE 4.

Summary of Statistics Pertaining to the Tumor Volume at Time of Treatment for U-251N Tumors Treated with 20 Gy and 9L Tumors Treated with 25 Gy

Summary of available volume at time of treatment data
Group n Mean volume ± standard error (mm3) Volume range [min, max] (mm3) Volume median (mm3)
U-251N 20 Gy 32 165.0 ± 22.0 [17.1, 553.2] 127.2
U-251N 20 Gy survivors 19 194.7 ± 32.9 [17.1, 553.2] 200.3
U-251N 20 Gy non-survivors 13 121.5 ± 21.0 [24.8, 278.8] 98.4
9L 25 Gy 41 85.2 ± 11.9 [10.0, 302.4] 61.3
9L 25 Gy survivors 14 50.6 ± 8.6 [13.6, 136.1] 40.2
9L 25 Gy non-survivors 27 103.1 ± 16.6 [10.0, 302.4] 71.1

Note. Data is presented in Table 5 and Fig. 6.